...
首页> 外文期刊>Cornea >Pseudohypopyon following intravitreal triamcinolone acetonide injection.
【24h】

Pseudohypopyon following intravitreal triamcinolone acetonide injection.

机译:玻璃体腔注射曲安奈德后注射伪低popyon。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE:: To report a case of a pseudohypopyon that developed after intravitreal injection of triamcinolone acetonide for choroidal neovascularization from age-related macular degeneration. METHODS:: Observational case report. RESULTS:: A 62-year-old woman received an intravitreal injection of triamcinolone acetonide for the treatment of a choroidal neovascular membrane that developed as a result of age-related macular degeneration. A layer of yellowish deposits was observed in the anterior chamber 1 day after the injection. The patient denied any pain or reduced vision, and there was no redness noted on examination. The deposits cleared spontaneously on the fourth postoperative day. CONCLUSIONS:: Pseudohypopyon may develop after intravitreal injection of triamcinolone acetonide. Distinguishing this from a true hypopyon is important because the treatment and prognosis are very different for the two conditions.
机译:目的:报告一例假性超融合蛋白,该病例在玻璃体内注射曲安奈德用于年龄相关性黄斑变性的脉络膜新生血管形成后发生。方法::观察病例报告。结果:一名62岁妇女接受玻璃体内注射曲安奈德治疗因年龄相关性黄斑变性而形成的脉络膜新生血管膜。注射后1天,在前房中观察到一层淡黄色的沉积物。该患者否认有任何疼痛或视力下降,并且检查时未发现发红现象。术后第四天自发清除沉积物。结论:玻璃体腔注射曲安奈德后可能会产生伪hypopyon。将其与真正的hypopyon区分开很重要,因为两种情况的治疗和预后都非常不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号